Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on MedAdvisor.
RELATED STOCKHEAD STORIES
News
Reporting Season Round Up: Leading the charge was Playside – the ASX’s local games developer
Experts
MoneyTalks: Here’s how patience pays off for investors in the ASX small cap space
Experts
MoneyTalks: Gleneagle gives us 3 good value stock picks for rampant times
News
Market highlights and 5 ASX small caps to watch on Thursday
News
Last Orders: What you might have missed on the ASX today
News
Last Orders: What you might have missed on the ASX today
News
Last Orders: What you might have missed on the ASX today
News
Last Orders: What you might have missed on the ASX today
News
Rise and Shine: What you need to know before the ASX opens
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Report calls for long-term investment in pandemic R&D
Health & Biotech
Mesoblast burnt $108m in FY20 waiting on key FDA ruling
Health & Biotech
MedAdvisor eyes off US health insurance market with new distribution deal
Health & Biotech
The healthcare winners and losers after COVID-19, and what comes next
Health & Biotech
Investors can’t get enough of telehealth as global funding surges in Q3
Director Trades
Directors Trades: This anti-snoring device maker needed capital to survive COVID-19; one director put in $3.7m
Tech
